Robert Davey | Profiles RNS

Robert Davey, PhD

Professor

Boston University School of Medicine

Dept of Microbiology

PhD, University of Adelaide

Websites

	University of Texas Medical Branch Department of Microbiology and Immunology
	LinkedIn
	National Emerging Infectious Diseases Laboratories Faculty

ORCID : 0000-0001-9168-2892

Dr. Robert Davey, PhD is a currently a Professor of Microbiology at the Boston University School of Medicine. Dr. Davey received his doctorate in Microbiology and Immunology at the University of Adelaide in Australia. He continued his training as a Postdoctoral Fellow at the Howard Hughes Medical Institute and then at the Division of Hematology, both with Dr. James Cunningham at Brigham and Women's Hospital and Harvard Medical School.

Dr. Davey's first academic appointment was as an Instructor in Medicine at Harvard. He then held an Assistant Professor position which he got promoted to Adjunct Associate Professor at the Department of Microbiology and Immunology at the University of Texas Medical Branch.

Dr. Davey was also a Ewing Halsell Scholar and Scientist at the Department of Virology and Immunology at the Texas Biomedical Research Institute. As a Scientist at the Texas Biomedical Research Institute, Dr. Davey's work was focused on identification of cellular factors important for establishing infection by filovirus and bunyaviruses. His work has culminated in a deeper understanding of the entry and cell signaling pathways that are used by these viruses to penetrate the cell membrane and establish infection. His work with Ebolavirus has been published in the high-impact journals PLoS Pathogens, PNAS and a new article on host factor dependence in Science that was featured on the cover page. Dr. Davey’s group works collaboratively with a number of groups providing sophisticated molecular biology and cell biology techniques for the study of pathogenic viruses including Ebolavirus for which the lab mainly works. He has developed high throughput screening techniques for Ebolavirus. He also performs contract work testing drugs and compounds for ebolavirus infection inhibition. His team is well trained in ABSL4 procedures and have been working with Ebolavirus since 2006.

From 2015-2017, Dr. Davey held the role of Interim Chair in the Department of Virology and Immunology at the Texas Biomedical Research Institute. He is also Director of ABSL4 at the Texas Biomedical Research Institute.

Faculty
Boston University
National Emerging Infectious Disease Lab

Member
Boston University School of Medicine
Evans Center for Interdisciplinary Biomedical Research

Graduate Faculty (Primary Mentor of Grad Students)
Boston University School of Medicine, Graduate Medical Sciences

2015 San Antonio business journal: Outstanding medical researcher, Healthcare heroes awards

2005 UTMB Graduate school teaching award

BU Research

Antiviral Lead Identification to Treat Filovirus Infections
08/12/2019 - 07/31/2023 (Subcontract PI)
Purdue University NIH NIAID
5R01AI128364-02

STTR Phase I: Aminomethyl benzamides as novel anti Ebola agents
08/16/2019 - 07/31/2022 (Subcontract PI)
Chicago BioSolutions, Inc. NIH NIAID
5R42AI126971-04

Neutralization and binding of antibody to virus by Regeneron antibodies
07/08/2020 - 06/30/2022 (Subcontract PI)
Regeneron Pharmaceuticals, Inc. HHS ASPR BARDA
HHSO100201700020C

Structural and Functional Characterization of the Ebola Virus Replication Complex (Core C)
07/01/2019 - 06/30/2021 (Subcontract PI)
The Washington University NIH NIAID
5P01AI120943-04

Structural and Functional Characterization of the Ebola Virus Replication Complex
07/01/2018 - 06/30/2021 (Subcontract PI)
The Washington University NIH NIAID
5P01AI120943-05

HTS for identification and evaluation of efficacy for therapeutics against SARS-CoV-2 infection
05/01/2020 - 04/30/2021 (Subcontract PI)
President & Fellows of Harvard College on behalf of Harvard Medical School China Evergrande Gr

Emerging virus-host cell protein interaction networks
08/01/2018 - 03/31/2021 (Subcontract PI)
Purdue University NIH NIAID
5R01AI114814-05

Small molecule inhibitors of Ebola virus polymerase function
08/01/2018 - 01/31/2021 (Subcontract PI)
Georgia State University NIH NIAID
5R01AI125453-04

Advanced development of a viral entry inhbitor as a therapeutic for arenavirus hemorrhagic fever
03/01/2020 - 12/31/2020 (Subcontract PI)
Kineta, Inc. NIH NIAID
5R01AI141102-02

Modeling Filovirus Infection of and Trafficking through Skin
08/01/2018 - 07/31/2020 (Subcontract PI)
The University of Iowa NIH NIAID
5R01AI134733-02

Title

Yr	Title	Project-Sub Proj	Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Morselli Gysi D, do Valle Í, Zitnik M, Ameli A, Gan X, Varol O, Ghiassian SD, Patten JJ, Davey RA, Loscalzo J, Barabási AL. Network medicine framework for identifying drug-repurposing opportunities for COVID-19. Proc Natl Acad Sci U S A. 2021 05 11; 118(19). PMID: 33906951

Mena EL, Donahue CJ, Vaites LP, Li J, Rona G, O'Leary C, Lignitto L, Miwatani-Minter B, Paulo JA, Dhabaria A, Ueberheide B, Gygi SP, Pagano M, Harper JW, Davey RA, Elledge SJ. ORF10-Cullin-2-ZYG11B complex is not required for SARS-CoV-2 infection. Proc Natl Acad Sci U S A. 2021 04 27; 118(17). PMID: 33827988

Patten JJ, Keiser PT, Gysi D, Menichetti G, Mori H, Donahue CJ, Gan X, Do Valle I, Geoghegan-Barek K, Anantpadma M, Berrigan JL, Jalloh S, Ayazika T, Wagner F, Zitnik M, Ayehunie S, Anderson D, Loscalzo J, Gummuluru S, Namchuk MN, Barabasi AL, Davey RA. Multidose evaluation of 6,710 drug repurposing library identifies potent SARS-CoV-2 infection inhibitors In Vitro and In Vivo. bioRxiv. 2021 Apr 22.View Related Profiles.

Davey, Robert
Gummuluru, Suryaram

PMID: 33907750

Novelli G, Liu J, Biancolella M, Alonzi T, Novelli A, Patten JJ, Cocciadiferro D, Agolini E, Colona VL, Rizzacasa B, Giannini R, Bigio B, Goletti D, Capobianchi MR, Grelli S, Mann J, McKee TD, Cheng K, Amanat F, Krammer F, Guarracino A, Pepe G, Tomino C, Tandjaoui-Lambiotte Y, Uzunhan Y, Tubiana S, Ghosn J, Notarangelo LD, Su HC, Abel L, Cobat A, Elhanan G, Grzymski JJ, Latini A, Sidhu SS, Jain S, Davey RA, Casanova JL, Wei W, Pandolfi PP. Inhibition of HECT E3 ligases as potential therapy for COVID-19. Cell Death Dis. 2021 03 24; 12(4):310. PMID: 33762578

Wang LL, Palermo N, Estrada L, Thompson C, Patten JJ, Anantpadma M, Davey RA, Xiang SH. Identification of filovirus entry inhibitors targeting the endosomal receptor NPC1 binding site. Antiviral Res. 2021 May; 189:105059. PMID: 33705865

Keiser PT, Anantpadma M, Staples H, Carrion R, Davey RA. Automation of Infectious Focus Assay for Determination of Filovirus Titers and Direct Comparison to Plaque and TCID50 Assays. Microorganisms. 2021 Jan 12; 9(1). PMID: 33445537

Hekman RM, Hume AJ, Goel RK, Abo KM, Huang J, Blum BC, Werder RB, Suder EL, Paul I, Phanse S, Youssef A, Alysandratos KD, Padhorny D, Ojha S, Mora-Martin A, Kretov D, Ash PEA, Verma M, Zhao J, Patten JJ, Villacorta-Martin C, Bolzan D, Perea-Resa C, Bullitt E, Hinds A, Tilston-Lunel A, Varelas X, Farhangmehr S, Braunschweig U, Kwan JH, McComb M, Basu A, Saeed M, Perissi V, Burks EJ, Layne MD, Connor JH, Davey R, Cheng JX, Wolozin BL, Blencowe BJ, Wuchty S, Lyons SM, Kozakov D, Cifuentes D, Blower M, Kotton DN, Wilson AA, Mühlberger E, Emili A. Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2. Mol Cell. 2021 Jan 07; 81(1):212.View Related Profiles. PMID: 33417854

Gorgulla C, Padmanabha Das KM, Leigh KE, Cespugli M, Fischer PD, Wang ZF, Tesseyre G, Pandita S, Shnapir A, Calderaio A, Gechev M, Rose A, Lewis N, Hutcheson C, Yaffe E, Luxenburg R, Herce HD, Durmaz V, Halazonetis TD, Fackeldey K, Patten JJ, Chuprina A, Dziuba I, Plekhova A, Moroz Y, Radchenko D, Tarkhanova O, Yavnyuk I, Gruber C, Yust R, Payne D, Näär AM, Namchuk MN, Davey RA, Wagner G, Kinney J, Arthanari H. A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening. iScience. 2021 Feb 19; 24(2):102021. PMID: 33426509

Hekman RM, Hume AJ, Goel RK, Abo KM, Huang J, Blum BC, Werder RB, Suder EL, Paul I, Phanse S, Youssef A, Alysandratos KD, Padhorny D, Ojha S, Mora-Martin A, Kretov D, Ash PEA, Verma M, Zhao J, Patten JJ, Villacorta-Martin C, Bolzan D, Perea-Resa C, Bullitt E, Hinds A, Tilston-Lunel A, Varelas X, Farhangmehr S, Braunschweig U, Kwan JH, McComb M, Basu A, Saeed M, Perissi V, Burks EJ, Layne MD, Connor JH, Davey R, Cheng JX, Wolozin BL, Blencowe BJ, Wuchty S, Lyons SM, Kozakov D, Cifuentes D, Blower M, Kotton DN, Wilson AA, Mühlberger E, Emili A. Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2. Mol Cell. 2020 12 17; 80(6):1104-1122.e9.View Related Profiles. PMID: 33259812; DOI: 10.1016/j.molcel.2020.11.028;

Cooper L, Schafer A, Li Y, Cheng H, Medegan Fagla B, Shen Z, Nowar R, Dye K, Anantpadma M, Davey RA, Thatcher GRJ, Rong L, Xiong R. Screening and Reverse-Engineering of Estrogen Receptor Ligands as Potent Pan-Filovirus Inhibitors. J Med Chem. 2020 10 08; 63(19):11085-11099. PMID: 32886512

Showing 10 of 100 results. Show More

Luthra P, Anantpadma M, De S, Sourimant J, Davey RA, Plemper RK, Basler CF. High-Throughput Screening Assay to Identify Small Molecule Inhibitors of Marburg Virus VP40 Protein. ACS Infect Dis. 2020 10 09; 6(10):2783-2799. PMID: 32870648

Akinci E, Cha M, Lin L, Yeo G, Hamilton MC, Donahue CJ, Bermudez-Cabrera HC, Zanetti LC, Chen M, Barkal SA, Khowpinitchai B, Chu N, Velimirovic M, Jodhani R, Fife JD, Sovrovic M, Cole PA, Davey RA, Cassa CA, Sherwood RI. Elucidation of remdesivir cytotoxicity pathways through genome-wide CRISPR-Cas9 screening and transcriptomics. bioRxiv. 2020 Aug 28. PMID: 32869031

Gorgulla C, PadmanabhaDas K, Leigh KE, Cespugli M, Fischer PD, Wang ZF, Tesseyre G, Pandita S, Shnapir A, Calderaio A, Hutcheson C, Gechev M, Rose A, Lewis N, Yaffe E, Luxenburg R, Herce HD, Durmaz V, Halazonetis TD, Fackeldey K, Patten JJ, Chuprina A, Dziuba I, Plekhova A, Moroz Y, Radchenko D, Tarkhanova O, Yavnyuk I, Gruber CC, Yust R, Payne D, Näär AM, Namchuk MN, Davey RA, Wagner G, Kinney J, Arthanari H. A Multi-Pronged Approach Targeting SARS-CoV-2 Proteins Using Ultra-Large Virtual Screening. ChemRxiv. 2020 Jul 24. PMID: 33200116

Lane TR, Massey C, Comer JE, Freiberg AN, Zhou H, Dyall J, Holbrook MR, Anantpadma M, Davey RA, Madrid PB, Ekins S. Pyronaridine tetraphosphate efficacy against Ebola virus infection in guinea pig. Antiviral Res. 2020 09; 181:104863. PMID: 32682926

Gaisina IN, Peet NP, Wong L, Schafer AM, Cheng H, Anantpadma M, Davey RA, Thatcher GRJ, Rong L. Discovery and Structural Optimization of 4-(Aminomethyl)benzamides as Potent Entry Inhibitors of Ebola and Marburg Virus Infections. J Med Chem. 2020 07 09; 63(13):7211-7225. PMID: 32490678

Pavlovich SS, Darling T, Hume AJ, Davey RA, Feng F, Mühlberger E, Kepler TB. Egyptian Rousette IFN-? Subtypes Elicit Distinct Antiviral Effects and Transcriptional Responses in Conspecific Cells. Front Immunol. 2020; 11:435.View Related Profiles.

Hume, Adam
Muhlberger, Elke
Feng, Feng
Davey, Robert
Kepler, Thomas

PMID: 32231668

Yurdakul C, Avci O, Matlock A, Devaux AJ, Quintero MV, Ozbay E, Davey RA, Connor JH, Karl WC, Tian L, Ünlü MS. High-Throughput, High-Resolution Interferometric Light Microscopy of Biological Nanoparticles. ACS Nano. 2020 02 25; 14(2):2002-2013.View Related Profiles.

Connor, John
Davey, Robert

PMID: 32003974

Lane TR, Massey C, Comer JE, Anantpadma M, Freundlich JS, Davey RA, Madrid PB, Ekins S. Repurposing the antimalarial pyronaridine tetraphosphate to protect against Ebola virus infection. PLoS Negl Trop Dis. 2019 11; 13(11):e0007890. PMID: 31751347

Wu Y, Pons V, Noël R, Kali S, Shtanko O, Davey RA, Popoff MR, Tordo N, Gillet D, Cintrat JC, Barbier J. DABMA: A Derivative of ABMA with Improved Broad-Spectrum Inhibitory Activity of Toxins and Viruses. ACS Med Chem Lett. 2019 Aug 08; 10(8):1140-1147. PMID: 31413797

Lane T, Anantpadma M, Freundlich JS, Davey RA, Madrid PB, Ekins S. The Natural Product Eugenol Is an Inhibitor of the Ebola Virus In Vitro. Pharm Res. 2019 May 17; 36(7):104. PMID: 31101988

Anantpadma M, Lane T, Zorn KM, Lingerfelt MA, Clark AM, Freundlich JS, Davey RA, Madrid PB, Ekins S. Ebola Virus Bayesian Machine Learning Models Enable New in Vitro Leads. ACS Omega. 2019 Jan 31; 4(1):2353-2361. PMID: 30729228

Batra J, Hultquist JF, Liu D, Shtanko O, Von Dollen J, Satkamp L, Jang GM, Luthra P, Schwarz TM, Small GI, Arnett E, Anantpadma M, Reyes A, Leung DW, Kaake R, Haas P, Schmidt CB, Schlesinger LS, LaCount DJ, Davey RA, Amarasinghe GK, Basler CF, Krogan NJ. Protein Interaction Mapping Identifies RBBP6 as a Negative Regulator of Ebola Virus Replication. Cell. 2018 12 13; 175(7):1917-1930.e13. PMID: 30550789

Cui Q, Cheng H, Xiong R, Zhang G, Du R, Anantpadma M, Davey RA, Rong L. Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus. Viruses. 2018 11 30; 10(12). PMID: 30513600

Lindstrom A, Anantpadma M, Baker L, Raghavendra NM, Davey R, Davisson VJ. Phenotypic Prioritization of Diphyllin Derivatives That Block Filoviral Cell Entry by Vacuolar (H+ )-ATPase Inhibition. ChemMedChem. 2018 12 20; 13(24):2664-2676. PMID: 30335906

Shtanko O, Reyes AN, Jackson WT, Davey RA. Autophagy-Associated Proteins Control Ebola Virus Internalization Into Host Cells. J Infect Dis. 2018 11 22; 218(suppl_5):S346-S354. PMID: 29947774; DOI: 10.1093/infdis/jiy294;

Pascal KE, Dudgeon D, Trefry JC, Anantpadma M, Sakurai Y, Murin CD, Turner HL, Fairhurst J, Torres M, Rafique A, Yan Y, Badithe A, Yu K, Potocky T, Bixler SL, Chance TB, Pratt WD, Rossi FD, Shamblin JD, Wollen SE, Zelko JM, Carrion R, Worwa G, Staples HM, Burakov D, Babb R, Chen G, Martin J, Huang TT, Erlandson K, Willis MS, Armstrong K, Dreier TM, Ward AB, Davey RA, Pitt MLM, Lipsich L, Mason P, Olson W, Stahl N, Kyratsous CA. Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates. J Infect Dis. 2018 11 22; 218(suppl_5):S612-S626. PMID: 29860496; DOI: 10.1093/infdis/jiy285;

Sakurai Y, Sakakibara N, Toyama M, Baba M, Davey RA. Novel amodiaquine derivatives potently inhibit Ebola virus infection. Antiviral Res. 2018 12; 160:175-182. PMID: 30395872

Luthra P, Naidoo J, Pietzsch CA, De S, Khadka S, Anantpadma M, Williams CG, Edwards MR, Davey RA, Bukreyev A, Ready JM, Basler CF. Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses. Antiviral Res. 2018 10; 158:288-302. PMID: 30144461

Cui Q, Du R, Anantpadma M, Schafer A, Hou L, Tian J, Davey RA, Cheng H, Rong L. Identification of Ellagic Acid from Plant Rhodiola rosea L. as an Anti-Ebola Virus Entry Inhibitor. Viruses. 2018 03 27; 10(4). PMID: 29584652; DOI: 10.3390/v10040152;

Shtanko O, Sakurai Y, Reyes AN, Noël R, Cintrat JC, Gillet D, Barbier J, Davey RA. Retro-2 and its dihydroquinazolinone derivatives inhibit filovirus infection. Antiviral Res. 2018 01; 149:154-163. PMID: 29175127; DOI: 10.1016/j.antiviral.2017.11.016;

Wu Y, Pons V, Goudet A, Panigai L, Fischer A, Herweg JA, Kali S, Davey RA, Laporte J, Bouclier C, Yousfi R, Aubenque C, Merer G, Gobbo E, Lopez R, Gillet C, Cojean S, Popoff MR, Clayette P, Le Grand R, Boulogne C, Tordo N, Lemichez E, Loiseau PM, Rudel T, Sauvaire D, Cintrat JC, Gillet D, Barbier J. ABMA, a small molecule that inhibits intracellular toxins and pathogens by interfering with late endosomal compartments. Sci Rep. 2017 Nov 14; 7(1):15567. PMID: 29138439; DOI: 10.1038/s41598-017-15466-7;

Davey RA, Shtanko O, Anantpadma M, Sakurai Y, Chandran K, Maury W. Mechanisms of Filovirus Entry. Curr Top Microbiol Immunol. 2017; 411:323-352. PMID: 28601947; DOI: 10.1007/82_2017_14;

Gupta N, Noël R, Goudet A, Hinsinger K, Michau A, Pons V, Abdelkafi H, Secher T, Shima A, Shtanko O, Sakurai Y, Cojean S, Pomel S, Liévin-Le Moal V, Leignel V, Herweg JA, Fischer A, Johannes L, Harrison K, Beard PM, Clayette P, Le Grand R, Rayner JO, Rudel T, Vacus J, Loiseau PM, Davey RA, Oswald E, Cintrat JC, Barbier J, Gillet D. Inhibitors of retrograde trafficking active against ricin and Shiga toxins also protect cells from several viruses, Leishmania and Chlamydiales. Chem Biol Interact. 2017 Apr 01; 267:96-103. PMID: 27712998; DOI: 10.1016/j.cbi.2016.10.005;

Anantpadma M, Kouznetsova J, Wang H, Huang R, Kolokoltsov A, Guha R, Lindstrom AR, Shtanko O, Simeonov A, Maloney DJ, Maury W, LaCount DJ, Jadhav A, Davey RA. Large-Scale Screening and Identification of Novel Ebola Virus and Marburg Virus Entry Inhibitors. Antimicrob Agents Chemother. 2016 08; 60(8):4471-81. PMID: 27161622; DOI: 10.1128/AAC.00543-16;

Chung DH, Golden JE, Adcock RS, Schroeder CE, Chu YK, Sotsky JB, Cramer DE, Chilton PM, Song C, Anantpadma M, Davey RA, Prodhan AI, Yin X, Zhang X. Discovery of a Broad-Spectrum Antiviral Compound That Inhibits Pyrimidine Biosynthesis and Establishes a Type 1 Interferon-Independent Antiviral State. Antimicrob Agents Chemother. 2016 08; 60(8):4552-62. PMID: 27185801; DOI: 10.1128/AAC.00282-16;

Wang B, Kluwe CA, Lungu OI, DeKosky BJ, Kerr SA, Johnson EL, Tanno H, Lee CH, Jung J, Rezigh AB, Carroll SM, Reyes AN, Bentz JR, Villanueva I, Altman AL, Davey RA, Ellington AD, Georgiou G. Corrigendum: Facile Discovery of a Diverse Panel of Anti-Ebola Virus Antibodies by Immune Repertoire Mining. Sci Rep. 2016 06 10; 6:27229. PMID: 27282782; DOI: 10.1038/srep27229;

Cap AP, Pidcoke HF, Keil SD, Staples HM, Anantpadma M, Carrion R, Davey RA, Frazer-Abel A, Taylor AL, Gonzales R, Patterson JL, Goodrich RP. Treatment of blood with a pathogen reduction technology using ultraviolet light and riboflavin inactivates Ebola virus in vitro. Transfusion. 2016 Mar; 56 Suppl 1:S6-15. PMID: 27001363; DOI: 10.1111/trf.13393;

Rhein BA, Powers LS, Rogers K, Anantpadma M, Singh BK, Sakurai Y, Bair T, Miller-Hunt C, Sinn P, Davey RA, Monick MM, Maury W. Interferon-? Inhibits Ebola Virus Infection. PLoS Pathog. 2015; 11(11):e1005263. PMID: 26562011; DOI: 10.1371/journal.ppat.1005263;

Ekins S, Freundlich JS, Clark AM, Anantpadma M, Davey RA, Madrid P. Machine learning models identify molecules active against the Ebola virus in vitro. F1000Res. 2015; 4:1091. PMID: 26834994; DOI: 10.12688/f1000research.7217.3;

Wang B, Kluwe CA, Lungu OI, DeKosky BJ, Kerr SA, Johnson EL, Tanno H, Lee, Jung J, Rezigh AB, Carroll SM, Reyes AN, Bentz JR, Villanueva I, Altman AL, Davey RA, Ellington AD, Georgiou G. Facile Discovery of a Diverse Panel of Anti-Ebola Virus Antibodies by Immune Repertoire Mining. Sci Rep. 2015 09 10; 5:13926. PMID: 26355042; DOI: 10.1038/srep13926;

Madrid PB, Panchal RG, Warren TK, Shurtleff AC, Endsley AN, Green CE, Kolokoltsov A, Davey R, Manger ID, Gilfillan L, Bavari S, Tanga MJ. Evaluation of Ebola Virus Inhibitors for Drug Repurposing. ACS Infect Dis. 2015 Jul 10; 1(7):317-26. PMID: 27622822

Leung DW, Borek D, Luthra P, Binning JM, Anantpadma M, Liu G, Harvey IB, Su Z, Endlich-Frazier A, Pan J, Shabman RS, Chiu W, Davey RA, Otwinowski Z, Basler CF, Amarasinghe GK. An Intrinsically Disordered Peptide from Ebola Virus VP35 Controls Viral RNA Synthesis by Modulating Nucleoprotein-RNA Interactions. Cell Rep. 2015 Apr 21; 11(3):376-89. PMID: 25865894; DOI: 10.1016/j.celrep.2015.03.034;

Sakurai Y, Kolokoltsov AA, Chen CC, Tidwell MW, Bauta WE, Klugbauer N, Grimm C, Wahl-Schott C, Biel M, Davey RA. Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment. Science. 2015 Feb 27; 347(6225):995-8. PMID: 25722412; DOI: 10.1126/science.1258758;

Gaziova I, Davey RA, Elferink LA. Identification of factors regulating MET receptor endocytosis by high-throughput siRNA screening. Methods Mol Biol. 2015; 1270:381-94. PMID: 25702130; DOI: 10.1007/978-1-4939-2309-0_26;

Nuckols JT, McAuley AJ, Huang YJ, Horne KM, Higgs S, Davey RA, Vanlandingham DL. pH-Dependent entry of chikungunya virus fusion into mosquito cells. Virol J. 2014 Dec 05; 11:215. PMID: 25476236; DOI: 10.1186/s12985-014-0215-y;

Kuhn JH, Andersen KG, Bào Y, Bavari S, Becker S, Bennett RS, Bergman NH, Blinkova O, Bradfute S, Brister JR, Bukreyev A, Chandran K, Chepurnov AA, Davey RA, Dietzgen RG, Doggett NA, Dolnik O, Dye JM, Enterlein S, Fenimore PW, Formenty P, Freiberg AN, Garry RF, Garza NL, Gire SK, Gonzalez JP, Griffiths A, Happi CT, Hensley LE, Herbert AS, Hevey MC, Hoenen T, Honko AN, Ignatyev GM, Jahrling PB, Johnson JC, Johnson KM, Kindrachuk J, Klenk HD, Kobinger G, Kochel TJ, Lackemeyer MG, Lackner DF, Leroy EM, Lever MS, Mühlberger E, Netesov SV, Olinger GG, Omilabu SA, Palacios G, Panchal RG, Park DJ, Patterson JL, Paweska JT, Peters CJ, Pettitt J, Pitt L, Radoshitzky SR, Ryabchikova EI, Saphire EO, Sabeti PC, Sealfon R, Shestopalov AM, Smither SJ, Sullivan NJ, Swanepoel R, Takada A, Towner JS, van der Groen G, Volchkov VE, Volchkova VA, Wahl-Jensen V, Warren TK, Warfield KL, Weidmann M, Nichol ST. Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names. Viruses. 2014 Sep; 6(9):3663-82.View Related Profiles.

Honko, Anna
Griffiths, Anthony
Muhlberger, Elke
Olinger, Gene
Davey, Robert

PMID: 25256396; PMCID: PMC4189044; DOI: 10.3390/v6093663;

Shtanko O, Nikitina RA, Altuntas CZ, Chepurnov AA, Davey RA. Crimean-Congo hemorrhagic fever virus entry into host cells occurs through the multivesicular body and requires ESCRT regulators. PLoS Pathog. 2014 Sep; 10(9):e1004390. PMID: 25233119; DOI: 10.1371/journal.ppat.1004390;

Chung DH, Jonsson CB, Tower NA, Chu YK, Sahin E, Golden JE, Noah JW, Schroeder CE, Sotsky JB, Sosa MI, Cramer DE, McKellip SN, Rasmussen L, White EL, Schmaljohn CS, Julander JG, Smith JM, Filone CM, Connor JH, Sakurai Y, Davey RA. Discovery of a novel compound with anti-venezuelan equine encephalitis virus activity that targets the nonstructural protein 2. PLoS Pathog. 2014 Jun; 10(6):e1004213.View Related Profiles.

Filone, Claire Marie
Connor, John
Davey, Robert

PMID: 24967809; PMCID: PMC4072787; DOI: 10.1371/journal.ppat.1004213;

Cheresiz SV, Kononova AA, Razumova YV, Dubich TS, Chepurnov AA, Kushch AA, Davey R, Pokrovsky AG. A vesicular stomatitis pseudovirus expressing the surface glycoproteins of influenza A virus. Arch Virol. 2014 Oct; 159(10):2651-8. PMID: 24888312

Li Y, Davey RA, Sivaramakrishnan S, Lynch WP. Postinhibitory rebound neurons and networks are disrupted in retrovirus-induced spongiform neurodegeneration. J Neurophysiol. 2014 Aug 01; 112(3):683-704. PMID: 25252336; DOI: 10.1152/jn.00227.2014;

Brown CS, Lee MS, Leung DW, Wang T, Xu W, Luthra P, Anantpadma M, Shabman RS, Melito LM, MacMillan KS, Borek DM, Otwinowski Z, Ramanan P, Stubbs AJ, Peterson DS, Binning JM, Tonelli M, Olson MA, Davey RA, Ready JM, Basler CF, Amarasinghe GK. In silico derived small molecules bind the filovirus VP35 protein and inhibit its polymerase cofactor activity. J Mol Biol. 2014 May 15; 426(10):2045-58. PMID: 24495995; DOI: 10.1016/j.jmb.2014.01.010;

Kuhn JH, Bào Y, Bavari S, Becker S, Bradfute S, Brauburger K, Rodney Brister J, Bukreyev AA, Caì Y, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Gonzalez JP, Formenty P, Freiberg AN, Hensley LE, Hoenen T, Honko AN, Ignatyev GM, Jahrling PB, Johnson KM, Klenk HD, Kobinger G, Lackemeyer MG, Leroy EM, Lever MS, Mühlberger E, Netesov SV, Olinger GG, Palacios G, Patterson JL, Paweska JT, Pitt L, Radoshitzky SR, Ryabchikova EI, Saphire EO, Shestopalov AM, Smither SJ, Sullivan NJ, Swanepoel R, Takada A, Towner JS, van der Groen G, Volchkov VE, Volchkova VA, Wahl-Jensen V, Warren TK, Warfield KL, Weidmann M, Nichol ST. Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA. Arch Virol. 2014 May; 159(5):1229-37.View Related Profiles.

Honko, Anna
Muhlberger, Elke
Olinger, Gene
Brauburger, Kristina
Davey, Robert

PMID: 24190508; PMCID: PMC4010566; DOI: 10.1007/s00705-013-1877-2;

Moller-Tank S, Kondratowicz AS, Davey RA, Rennert PD, Maury W. Role of the phosphatidylserine receptor TIM-1 in enveloped-virus entry. J Virol. 2013 Aug; 87(15):8327-41. PMID: 23698310; DOI: 10.1128/JVI.01025-13;

Madrid PB, Chopra S, Manger ID, Gilfillan L, Keepers TR, Shurtleff AC, Green CE, Iyer LV, Dilks HH, Davey RA, Kolokoltsov AA, Carrion R, Patterson JL, Bavari S, Panchal RG, Warren TK, Wells JB, Moos WH, Burke RL, Tanga MJ. A systematic screen of FDA-approved drugs for inhibitors of biological threat agents. PLoS One. 2013; 8(4):e60579. PMID: 23577127; DOI: 10.1371/journal.pone.0060579;

Kuhn JH, Bao Y, Bavari S, Becker S, Bradfute S, Brister JR, Bukreyev AA, Caì Y, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Gonzalez JP, Formenty P, Freiberg AN, Hensley LE, Honko AN, Ignatyev GM, Jahrling PB, Johnson KM, Klenk HD, Kobinger G, Lackemeyer MG, Leroy EM, Lever MS, Lofts LL, Mühlberger E, Netesov SV, Olinger GG, Palacios G, Patterson JL, Paweska JT, Pitt L, Radoshitzky SR, Ryabchikova EI, Saphire EO, Shestopalov AM, Smither SJ, Sullivan NJ, Swanepoel R, Takada A, Towner JS, van der Groen G, Volchkov VE, Wahl-Jensen V, Warren TK, Warfield KL, Weidmann M, Nichol ST. Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae. Arch Virol. 2013 Jun; 158(6):1425-32.View Related Profiles.

Honko, Anna
Muhlberger, Elke
Olinger, Gene
Davey, Robert

PMID: 23358612; PMCID: PMC3669655; DOI: 10.1007/s00705-012-1594-2;

Nuckols JT, Ziegler SA, Huang YJ, McAuley AJ, Vanlandingham DL, Klowden MJ, Spratt H, Davey RA, Higgs S. Infection of Aedes albopictus with chikungunya virus rectally administered by enema. Vector Borne Zoonotic Dis. 2013 Feb; 13(2):103-10. PMID: 23249139; DOI: 10.1089/vbz.2012.1013;

Kondratowicz AS, Hunt CL, Davey RA, Cherry S, Maury WJ. AMP-activated protein kinase is required for the macropinocytic internalization of ebolavirus. J Virol. 2013 Jan; 87(2):746-55. PMID: 23115293; DOI: 10.1128/JVI.01634-12;

Kuhn JH, Bao Y, Bavari S, Becker S, Bradfute S, Brister JR, Bukreyev AA, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Hensley LE, Honko AN, Jahrling PB, Johnson KM, Kobinger G, Leroy EM, Lever MS, Mühlberger E, Netesov SV, Olinger GG, Palacios G, Patterson JL, Paweska JT, Pitt L, Radoshitzky SR, Saphire EO, Smither SJ, Swanepoel R, Towner JS, van der Groen G, Volchkov VE, Wahl-Jensen V, Warren TK, Weidmann M, Nichol ST. Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Arch Virol. 2013 Jan; 158(1):301-11.View Related Profiles.

Honko, Anna
Muhlberger, Elke
Olinger, Gene
Davey, Robert

PMID: 23001720; PMCID: PMC3535543; DOI: 10.1007/s00705-012-1454-0;

Kim SO, Ives KL, Wang X, Davey RA, Chao C, Hellmich MR. Raf-1 kinase inhibitory protein (RKIP) mediates ethanol-induced sensitization of secretagogue signaling in pancreatic acinar cells. J Biol Chem. 2012 Sep 28; 287(40):33377-88. PMID: 22859298; DOI: 10.1074/jbc.M112.367656;

Sarkar S, Kantara C, Ortiz I, Swiercz R, Kuo J, Davey R, Escobar K, Ullrich R, Singh P. Progastrin overexpression imparts tumorigenic/metastatic potential to embryonic epithelial cells: phenotypic differences between transformed and nontransformed stem cells. Int J Cancer. 2012 Oct 01; 131(7):E1088-99. PMID: 22532325; PMCID: PMC3409332

Miller ME, Adhikary S, Kolokoltsov AA, Davey RA. Ebolavirus requires acid sphingomyelinase activity and plasma membrane sphingomyelin for infection. J Virol. 2012 Jul; 86(14):7473-83. PMID: 22573858; DOI: 10.1128/JVI.00136-12;

Chen Z, Kolokoltsov AA, Wang J, Adhikary S, Lorinczi M, Elferink LA, Davey RA. GRB2 interaction with the ecotropic murine leukemia virus receptor, mCAT-1, controls virus entry and is stimulated by virus binding. J Virol. 2012 Feb; 86(3):1421-32. PMID: 22090132; DOI: 10.1128/JVI.05993-11;

Kolokoltsov AA, Adhikary S, Garver J, Johnson L, Davey RA, Vela EM. Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin. Arch Virol. 2012 Jan; 157(1):121-7. PMID: 21947546; DOI: 10.1007/s00705-011-1115-8;

Eaves-Pyles T, Bu HF, Tan XD, Cong Y, Patel J, Davey RA, Strasser JE. Luminal-applied flagellin is internalized by polarized intestinal epithelial cells and elicits immune responses via the TLR5 dependent mechanism. PLoS One. 2011; 6(9):e24869. PMID: 21949773; DOI: 10.1371/journal.pone.0024869;

Mittler E, Kolesnikova L, Hartlieb B, Davey R, Becker S. The cytoplasmic domain of Marburg virus GP modulates early steps of viral infection. J Virol. 2011 Aug; 85(16):8188-96. PMID: 21680524; PMCID: PMC3147980

Desai MM, Gong B, Chan T, Davey RA, Soong L, Kolokoltsov AA, Sun J. Differential, type I interferon-mediated autophagic trafficking of hepatitis C virus proteins in mouse liver. Gastroenterology. 2011 Aug; 141(2):674-85, 685.e1-6. PMID: 21683701; DOI: 10.1053/j.gastro.2011.04.060;

Kondratowicz AS, Lennemann NJ, Sinn PL, Davey RA, Hunt CL, Moller-Tank S, Meyerholz DK, Rennert P, Mullins RF, Brindley M, Sandersfeld LM, Quinn K, Weller M, McCray PB, Chiorini J, Maury W. T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. Proc Natl Acad Sci U S A. 2011 May 17; 108(20):8426-31. PMID: 21536871; DOI: 10.1073/pnas.1019030108;

Hunt CL, Kolokoltsov AA, Davey RA, Maury W. The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus. J Virol. 2011 Jan; 85(1):334-47. PMID: 21047970; DOI: 10.1128/JVI.01278-09;

Saeed MF, Kolokoltsov AA, Albrecht T, Davey RA. Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog. 2010 Sep 16; 6(9):e1001110. PMID: 20862315; DOI: 10.1371/journal.ppat.1001110;

Gavicherla B, Ritchey L, Gianfelice A, Kolokoltsov AA, Davey RA, Ireton K. Critical role for the host GTPase-activating protein ARAP2 in InlB-mediated entry of Listeria monocytogenes. Infect Immun. 2010 Nov; 78(11):4532-41. PMID: 20823205; PMCID: PMC2976330

Chao C, Han X, Ives K, Park J, Kolokoltsov AA, Davey RA, Moyer MP, Hellmich MR. CCK2 receptor expression transforms non-tumorigenic human NCM356 colonic epithelial cells into tumor forming cells. Int J Cancer. 2010 Feb 15; 126(4):864-75. PMID: 19697327; DOI: 10.1002/ijc.24845;

Nawtaisong P, Keith J, Fraser T, Balaraman V, Kolokoltsov A, Davey RA, Higgs S, Mohammed A, Rongsriyam Y, Komalamisra N, Fraser MJ. Effective suppression of Dengue fever virus in mosquito cell cultures using retroviral transduction of hammerhead ribozymes targeting the viral genome. Virol J. 2009 Jun 04; 6:73. PMID: 19497123; DOI: 10.1186/1743-422X-6-73;

Kolokoltsov AA, Saeed MF, Freiberg AN, Holbrook MR, Davey RA. Identification of novel cellular targets for therapeutic intervention against Ebola virus infection by siRNA screening. Drug Dev Res. 2009 Jun 01; 70(4):255-265. PMID: 20930947

Wang E, Obeng-Adjei N, Ying Q, Meertens L, Dragic T, Davey RA, Ross SR. Mouse mammary tumor virus uses mouse but not human transferrin receptor 1 to reach a low pH compartment and infect cells. Virology. 2008 Nov 25; 381(2):230-40. PMID: 18829060; DOI: 10.1016/j.virol.2008.08.013;

Saeed MF, Kolokoltsov AA, Freiberg AN, Holbrook MR, Davey RA. Phosphoinositide-3 kinase-Akt pathway controls cellular entry of Ebola virus. PLoS Pathog. 2008 Aug 29; 4(8):e1000141. PMID: 18769720; DOI: 10.1371/journal.ppat.1000141;

Vela EM, Colpitts TM, Zhang L, Davey RA, Aronson JF. Pichindé virus is trafficked through a dynamin 2 endocytic pathway that is dependent on cellular Rab5- and Rab7-mediated endosomes. Arch Virol. 2008; 153(7):1391-6.View Related Profiles.

Davey, Robert
Colpitts, Tonya

PMID: 18543061

Kolokoltsova OA, Domina AM, Kolokoltsov AA, Davey RA, Weaver SC, Watowich SJ. Alphavirus production is inhibited in neurofibromin 1-deficient cells through activated RAS signalling. Virology. 2008 Jul 20; 377(1):133-42. PMID: 18485440; DOI: 10.1016/j.virol.2008.03.025;

Colpitts TM, Moore AC, Kolokoltsov AA, Davey RA. Venezuelan equine encephalitis virus infection of mosquito cells requires acidification as well as mosquito homologs of the endocytic proteins Rab5 and Rab7. Virology. 2007 Dec 05; 369(1):78-91.View Related Profiles.

Davey, Robert
Colpitts, Tonya

PMID: 17707875; PMCID: PMC2464296

Vela EM, Zhang L, Colpitts TM, Davey RA, Aronson JF. Arenavirus entry occurs through a cholesterol-dependent, non-caveolar, clathrin-mediated endocytic mechanism. Virology. 2007 Dec 05; 369(1):1-11.View Related Profiles.

Davey, Robert
Colpitts, Tonya

PMID: 17698159; PMCID: PMC2227908

Kolokoltsov AA, Deniger D, Fleming EH, Roberts NJ, Karpilow JM, Davey RA. Small interfering RNA profiling reveals key role of clathrin-mediated endocytosis and early endosome formation for infection by respiratory syncytial virus. J Virol. 2007 Jul; 81(14):7786-800. PMID: 17494077; DOI: 10.1128/JVI.02780-06;

Deniger DC, Kolokoltsov AA, Moore AC, Albrecht TB, Davey RA. Targeting and penetration of virus receptor bearing cells by nanoparticles coated with envelope proteins of Moloney murine leukemia virus. Nano Lett. 2006 Nov; 6(11):2414-21. PMID: 17090066; DOI: 10.1021/nl061180z;

Kolokoltsov AA, Wang E, Colpitts TM, Weaver SC, Davey RA. Pseudotyped viruses permit rapid detection of neutralizing antibodies in human and equine serum against Venezuelan equine encephalitis virus. Am J Trop Med Hyg. 2006 Oct; 75(4):702-9.View Related Profiles.

Davey, Robert
Colpitts, Tonya

PMID: 17038698

Fleming EH, Kolokoltsov AA, Davey RA, Nichols JE, Roberts NJ. Respiratory syncytial virus F envelope protein associates with lipid rafts without a requirement for other virus proteins. J Virol. 2006 Dec; 80(24):12160-70. PMID: 17005642; DOI: 10.1128/JVI.00643-06;

Chao C, Goluszko E, Lee YT, Kolokoltsov AA, Davey RA, Uchida T, Townsend CM, Hellmich MR. Constitutively active CCK2 receptor splice variant increases Src-dependent HIF-1 alpha expression and tumor growth. Oncogene. 2007 Feb 15; 26(7):1013-9. PMID: 16909104; DOI: 10.1038/sj.onc.1209862;

Negi SS, Kolokoltsov AA, Schein CH, Davey RA, Braun W. Determining functionally important amino acid residues of the E1 protein of Venezuelan equine encephalitis virus. J Mol Model. 2006 Sep; 12(6):921-9. PMID: 16607494; DOI: 10.1007/s00894-006-0101-7;

Saeed MF, Kolokoltsov AA, Davey RA. Novel, rapid assay for measuring entry of diverse enveloped viruses, including HIV and rabies. J Virol Methods. 2006 Aug; 135(2):143-50. PMID: 16584792; DOI: 10.1016/j.jviromet.2006.02.011;

Simmons A, Whitehead RP, Kolokoltsov AA, Davey RA. Use of recombinant lentivirus pseudotyped with vesicular stomatitis virus glycoprotein G for efficient generation of human anti-cancer chimeric T cells by transduction of human peripheral blood lymphocytes in vitro. Virol J. 2006 Feb 28; 3:8. PMID: 16507098; DOI: 10.1186/1743-422X-3-8;

Kolokoltsov AA, Fleming EH, Davey RA. Venezuelan equine encephalitis virus entry mechanism requires late endosome formation and resists cell membrane cholesterol depletion. Virology. 2006 Apr 10; 347(2):333-42. PMID: 16427678; DOI: 10.1016/j.virol.2005.11.051;

Chao C, Ives KL, Goluszko E, Kolokoltsov AA, Davey RA, Townsend CM, Hellmich MR. SRC regulates constitutive internalization and rapid resensitization of a cholecystokinin 2 receptor splice variant. J Biol Chem. 2005 Sep 30; 280(39):33368-73. PMID: 16079138; DOI: 10.1074/jbc.M506337200;

Kolokoltsov AA, Weaver SC, Davey RA. Efficient functional pseudotyping of oncoretroviral and lentiviral vectors by Venezuelan equine encephalitis virus envelope proteins. J Virol. 2005 Jan; 79(2):756-63. PMID: 15613303; DOI: 10.1128/JVI.79.2.756-763.2005;

Kolokoltsov AA, Davey RA. Rapid and sensitive detection of retrovirus entry by using a novel luciferase-based content-mixing assay. J Virol. 2004 May; 78(10):5124-32. PMID: 15113894

Barnett AL, Davey RA, Cunningham JM. Modular organization of the Friend murine leukemia virus envelope protein underlies the mechanism of infection. Proc Natl Acad Sci U S A. 2001 Mar 27; 98(7):4113-8. PMID: 11274436; DOI: 10.1073/pnas.071432398;

Davey RA, Zuo Y, Cunningham JM. Identification of a receptor-binding pocket on the envelope protein of friend murine leukemia virus. J Virol. 1999 May; 73(5):3758-63. PMID: 10196270

Kuss BJ, O'Neill GM, Eyre H, Doggett NA, Callen DF, Davey RA. ARA, a novel ABC transporter, is located at 16p13.1, is deleted in inv(16) leukemias, and is shown to be expressed in primitive hematopoietic precursors. Genomics. 1998 Aug 01; 51(3):455-8. PMID: 9721217

Davey RA, Hamson CA, Healey JJ, Cunningham JM. In vitro binding of purified murine ecotropic retrovirus envelope surface protein to its receptor, MCAT-1. J Virol. 1997 Nov; 71(11):8096-102. PMID: 9343158

Fass D, Davey RA, Hamson CA, Kim PS, Cunningham JM, Berger JM. Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution. Science. 1997 Sep 12; 277(5332):1662-6. PMID: 9287219

Marigo V, Davey RA, Zuo Y, Cunningham JM, Tabin CJ. Biochemical evidence that patched is the Hedgehog receptor. Nature. 1996 Nov 14; 384(6605):176-9. PMID: 8906794; DOI: 10.1038/384176a0;

Davey RA, Mayrhofer G, Ey PL. Identification of a broad-specificity nucleoside transporter with affinity for the sugar moiety in Giardia intestinalis trophozoites. Biochim Biophys Acta. 1992 Aug 24; 1109(2):172-8. PMID: 1520693

Ey PL, Davey RA, Duffield GA. A low-affinity nucleobase transporter in the protozoan parasite Giardia intestinalis. Biochim Biophys Acta. 1992 Aug 24; 1109(2):179-86. PMID: 1520694

Davey RA, Ey PL, Mayrhofer G. Characteristics of thymidine transport in Giardia intestinalis trophozoites. Mol Biochem Parasitol. 1991 Oct; 48(2):163-71. PMID: 1762628

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 100 publications over 25 distinct years, with a maximum of 9 publications in 2020

Bar chart showing 100 publications over 25 distinct years, with a maximum of 9 publications in 2020

Year	Publications
1991	1
1992	2
1996	1
1997	2
1998	1
1999	1
2001	1
2004	1
2005	2
2006	8
2007	3
2008	4
2009	2
2010	4
2011	6
2012	6
2013	4
2014	7
2015	7
2016	5
2017	3
2018	8
2019	4
2020	9
2021	8

Media Mentions
Featured Videos

Robert Davey, Ph.D., Chair Virology & Immunology

Recent (within 3 months)

ONE YEAR LATER: LESSONS FROM THE PANDEMIC

BU Today 3/16/2021

Older

In It Together 6/2/2020

WGBH 6/2/2020

BU Scientists Awarded $1.9 Million to Accelerate Coronavirus Research

BU Today 5/13/2020

Massachusetts Consortium Tests Thousands Of Existing Drugs Against Coronavirus

CBS Boston 5/13/2020

Decoding COVID-19

PBS Nova 5/13/2020

BU Labs, Researchers and Students Fight COVID-19

The Daily Free Press 4/29/2020

Episode 195: Does New England Have Enough COVID-19 Tests; The Fight To Save Yiddish

New England News Collaborative 4/23/2020

Will Antibody Testing Help Get People Back to Work?

PBS Newshour 4/21/2020

Needles In A Haystack: Could Existing Drugs Treat COVID-19?

WGBH 4/15/2020

Getting to Know the Enemy

WGBH 4/10/2020

BU NEIDL Scientists Can “See Enemy,” Making Headway on COVID-19 Research

Mirage News 4/7/2020

Coming: A New Appreciation For The Social Benefits Of Graduate Education

Forbes 4/6/2020

Get A Peek Inside The Search For COVID-19 DrugsL

Futurity 3/23/2020

Boston Researchers on the Frontline in the Battle Against Coronavirus

Boston 25 News 3/20/2020

Live Coronavirus Research Gets Underway at BU NEIDL

BU Today 2/19/2020

Ebola Treatment Massively Cuts Death Rate, But It’s No Cure

Futurity 8/16/2019

Malaria Drug Shows Promise For Treating Ebola

Futurity 11/30/2018

Old Drug, New Tricks

BU Today 11/19/2018

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Marburg
Ebolavirus
ABSL4
Virology
Immunology
bunyaviruses
arenaviruses
Junin virus
Lassa Fever
Filoviruses

Contact for Mentoring:

620 Albany Street
Boston MA 02118
Google Map

617.358.9166

Download vCard

Davey's Networks

Click the "See All" links for more information and interactive visualizations

Concepts

See all (487) concept(s)

Media Mentions

Co-Authors

See all (36) people

Similar People

See all (60) people

Same Department

Search Department